Clinical Trials Directory

Trials / Unknown

UnknownNCT02147262

Laboratory Characteristics in Chronic Atrophic Acrodermatitis

Inflammatory Proteins,Gene Polymorphisms, and Transcriptome Profiles in Patients With Chronic Atrophic Acrodermatitis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University Medical Centre Ljubljana · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective of this study is to characterize the inflammatory proteins, gene polymorphisms, and transcriptome profiles in patients with chronic atrophic dermatitis to gain better insight into pathogenesis of chronic infection with Borrelia burgdorferi sensu lato.

Conditions

Interventions

TypeNameDescription
DRUGdoxycycline orally, 100 mg, bid, 14 days
DRUGdoxycycline orally, 100 mg, bid, 28 days

Timeline

Start date
2013-07-01
Primary completion
2020-07-01
Completion
2020-07-01
First posted
2014-05-26
Last updated
2018-05-04

Locations

1 site across 1 country: Slovenia

Source: ClinicalTrials.gov record NCT02147262. Inclusion in this directory is not an endorsement.